Signal from the log
Eterna Regeneratives
4 M$ · Seed · United Kingdom · Medtech
Eterna Regeneratives fabrique un biomatériau à base de kératine qui vise à faire repousser l'émail dentaire et l'os. L'émail ne se régénère pas seul, et le fluor comme les résines ne font que consolider ou boucher ce qui reste. La société est un essaimage de la faculté d'odontologie de King's College London.
Article
Announced on , logged by the watch of 17 September 2026.
- Operation
- Funding round
- Announced amount
- 4 M$
- Stage
- Seed
- Country
- United Kingdom
- Sector
- Medtech
What the log says
Editorial note, in French
Sujet traité. L'article donne les sources et la position de Bolus.
The investors
Led by Hoxton Ventures , The Venture Collective
Provenance
Source prnewswire
Logged on 17 September 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Article The operation led to an article, with its sources checked one by one.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.